NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | Predicted membrane proteins
| | | | | Tissue enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Enzymes
| | | | | Group enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CLEC18A | C-type lectin domain family 18, member A | Predicted secreted proteins
| | | | | Group enriched |
FAM151A | Family with sequence similarity 151, member A | | | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
UPP2 | Uridine phosphorylase 2 | Enzymes
| | | | | Tissue enriched |
CLEC18B | C-type lectin domain family 18, member B | Predicted secreted proteins
| | | | | Group enriched |
HRSP12 | Heat-responsive protein 12 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
NKAIN4 | Na+/K+ transporting ATPase interacting 4 | Predicted membrane proteins
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
RIPPLY1 | Ripply transcriptional repressor 1 | Predicted secreted proteins
| | | | | Group enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM27 | Transmembrane protein 27 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
CTXN3 | Cortexin 3 | Predicted membrane proteins
| | | | | Tissue enriched |
DLGAP2 | Discs, large (Drosophila) homolog-associated protein 2 | Nuclear receptors
| | | | | Group enriched |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
OR2T10 | Olfactory receptor, family 2, subfamily T, member 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
UGT2B7 | UDP glucuronosyltransferase 2 family, polypeptide B7 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
C16orf11 | Chromosome 16 open reading frame 11 | | | | | | Tissue enriched |
CDH16 | Cadherin 16, KSP-cadherin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
GLYAT | Glycine-N-acyltransferase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
HMX2 | H6 family homeobox 2 | Transcription factors
| | | | | Tissue enriched |
LHX1 | LIM homeobox 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
LPPR1 | Lipid phosphate phosphatase-related protein type 1 | Predicted membrane proteins
| | | | | Group enriched |
MYOM3 | Myomesin 3 | | | | | | Group enriched |
PAX2 | Paired box 2 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Group enriched |
PTH1R | Parathyroid hormone 1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC47A2 | Solute carrier family 47 (multidrug and toxin extrusion), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ACOT6 | Acyl-CoA thioesterase 6 | | | | | | Group enriched |
CLCNKA | Chloride channel, voltage-sensitive Ka | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
CLCNKB | Chloride channel, voltage-sensitive Kb | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CRYAA | Crystallin, alpha A | Disease related genes Plasma proteins
| | | | | Tissue enriched |
CRYBB3 | Crystallin, beta B3 | Disease related genes
| | | | | Tissue enriched |
CYS1 | Cystin 1 | | | | | | Tissue enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
DUSP15 | Dual specificity phosphatase 15 | Enzymes
| | | | | Group enriched |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FMO1 | Flavin containing monooxygenase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |